Insulin Therapy for Postreperfusion Hyperglycemia

PHASE4RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

December 15, 2024

Study Completion Date

December 31, 2024

Conditions
Hyperglycaemia (Diabetic)Liver Transplantation
Interventions
DRUG

Insulin

If blood glucose level after reperfusion of liver graft exceeds 180 mg/dL, the insulin dose proposed by the linear mixed effects analysis is given as a bolus.

Trial Locations (1)

110-799

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER